A Sensitive Precolumn Derivatization Method for Determination of Piperazine in Vortioxetine Hydrobromide Using a C8 Column and High-Performance Liquid Chromatography-Mass Spectrometry

被引:16
作者
Dong, Shubo [1 ]
Yan, Zhengyu [1 ]
Yang, Hanyue [2 ]
机构
[1] China Pharmaceut Univ, Longmian Rd 639, Nanjing 210000, Jiangsu, Peoples R China
[2] Jiangsu Deyuan Pharmaceut Co Ltd, Jinqiao Rd 21, Lianyungang 222002, Jiangsu, Peoples R China
关键词
Piperazine; dansyl chloride; vortioxetine; LC-MS; genotoxic impurity; HYDROPHILIC INTERACTION CHROMATOGRAPHY; POLAR COMPOUNDS; HUMAN PLASMA; QUANTIFICATION;
D O I
10.2116/analsci.32.1333
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
A rapid and sensitive high-performance liquid chromatography-mass spectrometry method was established to determine the trace residues of piperazine in vortioxetine hydrobromide. The presence of piperazine was determined by precolumn derivatization with dansyl chloride. Chromatographic separation was performed on a Waters SunFire C8 column (150 x 4.6 mm, 3.5 mu m) in gradient elution mode, using formic acid and acetonitrile as mobile phase. Detection was performed in a single quadrupole mass spectrometer in single ion monitoring mode using positive ionization. An m/z value of 553 was selected for monitoring disubstituted piperazine by DNS-Cl. Linearity, accuracy, and precision were found to be acceptable over the piperazine concentration range of 0.3525 - 2.35 ng mL(-1). The limit of detection and limit of quantification of piperazine were 0.1175 and 0.3525 ng mL(-)1, respectively, which complied with the requirements of qualitative and quantitative analyses. The method was deemed sensitive and efficient.
引用
收藏
页码:1333 / 1338
页数:6
相关论文
共 26 条
  • [1] [Anonymous], 2014, INT C HARM TECHN REQ
  • [2] Comparison of hydrophilic interaction and reversed-phase liquid chromatography coupled with tandem mass spectrometric detection for the determination of three pharmaceuticals in human plasma
    Apostolou, Constantinos
    Kousoulos, Constantinos
    Dotsikas, Yannis
    Loukas, Yannis L.
    [J]. BIOMEDICAL CHROMATOGRAPHY, 2008, 22 (12) : 1393 - 1402
  • [3] Conners Gregory P., 1995, Journal of Emergency Medicine, V13, P341, DOI 10.1016/0736-4679(95)00009-Y
  • [4] Determination of piperazine in pharmaceutical drug substances using capillary electrophoresis with indirect UV detection
    Denis, CA
    Baryla, NE
    [J]. JOURNAL OF CHROMATOGRAPHY A, 2006, 1110 (1-2) : 268 - 271
  • [5] VORTIOXETINE FOR THE TREATMENT OF MAJOR DEPRESSION
    Dhir, A.
    [J]. DRUGS OF TODAY, 2013, 49 (12) : 781 - 790
  • [6] Synthetic approaches to the 2013 new drugs
    Ding, Hong X.
    Leverett, Carolyn A.
    Kyne, Robert E., Jr.
    Liu, Kevin K. -C.
    Fink, Sarah J.
    Flick, Andrew C.
    O'Donnell, Christopher J.
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2015, 23 (09) : 1895 - 1922
  • [7] HILIC-MS Determination of Genotoxic Impurity of 2-Chloro-N-(2-Chloroethyl)Ethanamine in the Vortioxetine Manufacturing Process
    Dousa, Michal
    Klvana, Robert
    Doubsky, Jan
    Srbek, Jan
    Richter, Jindrich
    Exner, Marek
    Gibala, Petr
    [J]. JOURNAL OF CHROMATOGRAPHIC SCIENCE, 2016, 54 (02) : 119 - 124
  • [8] URINARY PIPERAZINE EXCRETION IN HEALTHY CAUCASIANS
    FLETCHER, KA
    EVANS, DAP
    KELLY, JA
    [J]. ANNALS OF TROPICAL MEDICINE AND PARASITOLOGY, 1982, 76 (01): : 77 - 82
  • [9] Accurate HPLC determination of piperazine residues in the presence of other secondary and primary amines
    Gadzala-Kopciuch, R
    [J]. JOURNAL OF LIQUID CHROMATOGRAPHY & RELATED TECHNOLOGIES, 2005, 28 (14) : 2211 - 2223
  • [10] Vortioxetine: First Global Approval
    Gibb, Andrew
    Deeks, Emma D.
    [J]. DRUGS, 2014, 74 (01) : 135 - 145